Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniela, Etro"'
Autor:
Luca M. Neri, Francesca Buontempo, Keqiang Ye, Silvia Missiroli, Silvano Capitani, Daniela Etro
Publikováno v:
The International Journal of Biochemistry & Cell Biology. 41:570-577
Erythroid differentiation of human erythroleukemia cell line K562 induced by erythropoietin is a complex process that involves modifications at nuclear level, including nuclear translocation of phosphatidyl-inositol 3-kinase. In this work we show tha
Publikováno v:
The Women's Oncology Review. 5:223-225
Autor:
Tulin Ersahin, Serif Senturk, Daniela Etro, Maria Luca Neri, Francesca Buontempo, Silvia Missiroli, Silvano Capitani, Rengul Cetin-Atalay, Mehmet Ozturk
Publikováno v:
Investigational New Drugs
Cataloged from PDF version of article. The serine/threonine kinase Akt, a downstream effector of phosphatidylinositol 3-kinase (PI3K), is involved in cell survival and anti-apoptotic signaling. Akt has been shown to be constitutively expressed in a v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a145437d8594ed7aca9a4710250997
https://avesis.deu.edu.tr/publication/details/9a219cc8-54ad-4536-8c10-e0e198718d17/oai
https://avesis.deu.edu.tr/publication/details/9a219cc8-54ad-4536-8c10-e0e198718d17/oai
Autor:
Daniela, Etro, Mirko, Pinotti, Karin, Wulff, Giovanna, Marchetti, Angiola, Rocino, Falko H, Herrmann, Francesco, Bernardi
Publikováno v:
Haematologica. 88(12)
Autor:
Mirko, Pinotti, Daniela, Etro, Debora, Bindini, Maria Luisa, Papa, Giuseppina, Rodorigo, Angiola, Rocino, Guglielmo, Mariani, Nicola, Ciavarella, Francesco, Bernardi, Marko, Pinotti, Dániela, Etro, Guglieuto, Mariani
Publikováno v:
Blood. 99(4)
Two cross-reacting material–positive (CRM+) factor VII (FVII) mutations, associated with similar reductions in coagulant activity (2.5%) but with mild to asymptomatic (Gly331Ser, c184 [in chymotrypsin numbering]) or severe (Gly283Ser, c140) hemorrh
Autor:
Francesca Amoroso, Sonja Boldt, Georg Fuellen, Olaf Wolkenhauer, Daniela Etro, Mathias Freund, Sabine Ruck, Catrin Schult, Sandra Lange, Aenne Glass, Mandy Sawitzky, Luca M. Neri, Christian Junghanss, Meike Dahlhaus
Publikováno v:
BMC Cancer
BMC Cancer, Vol 10, Iss 1, p 560 (2010)
BMC Cancer, Vol 10, Iss 1, p 560 (2010)
BackgroundTargeted therapy approaches have been successfully introduced into the treatment of several cancers. The multikinase inhibitor Sorafenib has antitumor activity in solid tumors and its effects on acute lymphoblastic leukemia (ALL) cells are